InvestorsHub Logo
Followers 1692
Posts 205039
Boards Moderated 11
Alias Born 01/02/2008

Re: matt24d post# 341103

Tuesday, 03/03/2015 7:25:22 AM

Tuesday, March 03, 2015 7:25:22 AM

Post# of 641191
Oncolytics Biotech confirms the FDA granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers (ONCY) :

In 2015 Orions will be a Happy Trading Board.. stop by and make money wiht us...

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.